HEREDITARY HEMORRHAGIC TELANGIECTASIA

Clinical trials for HEREDITARY HEMORRHAGIC TELANGIECTASIA explained in plain language.

Never miss a new study

Get alerted when new HEREDITARY HEMORRHAGIC TELANGIECTASIA trials appear

Sign up with your email to follow new studies for HEREDITARY HEMORRHAGIC TELANGIECTASIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Trials to join now! 1 Not yet finished but already full! 2 Completed 1

New drug trial aims to tame debilitating nosebleeds in rare disorder

Disease control Recruiting now

This study is testing a new drug called ALN-6400 to see if it is safe and can help control bleeding in adults with hereditary hemorrhagic telangiectasia (HHT), a disorder that causes frequent, severe nosebleeds. The first part tests single doses in healthy volunteers, and the sec…

Matched conditions: HEREDITARY HEMORRHAGIC TELANGIECTASIA

Phase: PHASE1, PHASE2 • Sponsor: Alnylam Pharmaceuticals • Aim: Disease control

Last updated Apr 02, 2026 14:57 UTC

HEREDITARY HEMORRHAGIC TELANGIECTASIA

Get alerted when new HEREDITARY HEMORRHAGIC TELANGIECTASIA trials appear

New drug trial aims to tame debilitating nosebleeds in rare disorder